Decoy Therapeutics Inc. Share Price
NASDAQ: DCOY | Micro CapDecoy Therapeutics Inc. Stock Performance
Decoy Therapeutics Inc. Share Price Today
As of 31 October 2026, Decoy Therapeutics Inc.'s share price is $1.08. The stock opened at $1.20, compared to its previous close of $1.21. During today's trading session, Decoy Therapeutics Inc.'s share price traded between $1.08 and $1.22, with an average price of $1.15. Over the past 52 weeks, the stock has recorded a high of $13.51 and a low of $0.57. In terms of performance, Decoy Therapeutics Inc.'s share price has declined by 80.51% over the last six months and is up 39.90% on a year-on-year basis.
Decoy Therapeutics Inc. Share Price Chart
Decoy Therapeutics Inc. Quarterly Profit & Loss
All figures in USD
About Decoy Therapeutics Inc.
Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.
Decoy Therapeutics Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.92 | $1.08 | -45.04% |
Sep 2026 | $2.89 | $1.97 | -35.36% |
Aug 2026 | $4.20 | $3.04 | -25.31% |
Jul 2026 | $6.29 | $4.07 | -44.78% |
Jun 2026 | $9.09 | $7.37 | -6.23% |
May 2026 | $5.49 | $7.86 | +41.88% |
Apr 2026 | $6.27 | $5.54 | -17.44% |
Mar 2026 | $0.68 | $6.71 | +879.56% |
Feb 2026 | $0.69 | $0.69 | -11.27% |
Jan 2026 | $0.80 | $0.77 | N/A |